External Validity of the Cardiovascular Health Study
- 1 August 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medical Care
- Vol. 47 (8), 916-923
- https://doi.org/10.1097/mlr.0b013e318197b104
Abstract
Background: The Cardiovascular Health Study (CHS), a population-based prospective cohort study, has been used to identify major risk factors associated with cardiovascular disease and stroke in the elderly. Objective: To assess the external validity of the CHS. Research Design: Comparison of the CHS cohort to a national cohort of Medicare beneficiaries and to Medicare beneficiaries residing in the CHS geographic regions. Subjects: CHS participants and a 5% sample of Medicare beneficiaries. Measures: Demographic and administrative characteristics, comorbid conditions, resource use, and mortality. Results: Compared with both Medicare cohorts, the CHS cohort was older and included more men and African American participants. CHS participants were more likely to be enrolled in Medicare managed care than beneficiaries in the national Medicare cohort. Compared with the Medicare cohorts, mortality in the CHS was more than 40% lower at 1 year, approximately 25% lower at 5 years, and approximately 15% lower at 10 years. There were minimal differences in comorbid conditions and health care resource use. Conclusion: The CHS cohort is comparable with the Medicare population, particularly with regard to comorbid conditions and resource use, but had lower mortality. The difference in mortality may reflect the CHS recruitment strategy or volunteer bias. These findings suggest it may not be appropriate to project absolute rates of disease and outcomes based on CHS data to the entire Medicare population. However, there is no reason to expect that the relative risks associated with physiologic processes identified by CHS data would differ for nonparticipants.Keywords
This publication has 22 references indexed in Scilit:
- Marital status and longevity in the United States populationJournal of Epidemiology and Community Health, 2006
- Cystatin C and the Risk of Death and Cardiovascular Events among Elderly PersonsThe New England Journal of Medicine, 2005
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005
- Impact of functional support on health‐related quality of life in patients with colorectal cancerCancer, 2004
- Lp(a) Lipoprotein, Vascular Disease, and Mortality in the ElderlyThe New England Journal of Medicine, 2003
- Quality of Care of Nursing Home Residents Hospitalized With Heart FailureJournal of the American Geriatrics Society, 2002
- Administrative Data for Public Health Surveillance and PlanningAnnual Review of Public Health, 2001
- Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older AdultsThe New England Journal of Medicine, 1999
- Recruitment of adults 65 years and older as participants in the cardiovascular health studyAnnals of Epidemiology, 1993
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991